Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.54 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | TERT | O14746 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | BLM | P54132 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | FABP4 | P15090 | 2/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | PPARG | P37231 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | PPARD | Q03181 | 2/20 | 0.46 |
| ▸ | PPARA | Q07869 | 2/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6904870 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL9860452 | 1.00 | — | — | |
| SCHEMBL14353603 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL9275833 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL3682877 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL25258657 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL14353605 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL11662010 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL4194703 | 1.00 | — | — | |
| SCHEMBL4507788 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3527593-B1 | ISOCYANATE COMPOSITION, METHOD FOR PRODUCING ISOCYANATE COMPOSITION, AND METHOD FOR PRODUCING ISOCYANATE POLYMER | ASAHI CHEMICAL IND (JP) | 2025-07-23 | — | — | EP | disclosed |
| EP-3527600-B1 | ISOCYANATE COMPOSITION AND PRODUCTION METHOD FOR ISOCYANATE POLYMER | ASAHI CHEMICAL IND (JP) | 2025-07-09 | — | — | EP | disclosed |
| CN-112979917-B | Isocyanate composition, method for producing isocyanate composition, and method for producing isocyanate polymer | 旭化成株式会社 | 2023-04-25 | — | — | CN | disclosed |
| US-20230114799-A1 | ISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANATE POLYMER | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-04-13 | — | — | US | disclosed |
| US-11548975-B2 | Isocyanate composition and method for producing isocyanate polymer | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-01-10 | — | — | US | disclosed |
| CN-109790269-B | Isocyanate composition, method for producing isocyanate composition, and method for producing isocyanate polymer | 旭化成株式会社 | 2022-06-14 | — | — | CN | disclosed |
| CN-109803992-B | Isocyanate composition and method for producing isocyanate polymer | 旭化成株式会社 | 2022-05-24 | — | — | CN | disclosed |
| EP-3536683-B1 | POLYISOCYANATE COMPOSITION AND ISOCYANATE POLYMER COMPOSITION | ASAHI CHEMICAL IND (JP) | 2021-11-24 | — | — | EP | disclosed |
| CN-107963982-B | Polyisocyanate composition and isocyanate polymer composition | 旭化成株式会社 | 2021-11-12 | — | — | CN | disclosed |
| US-11118001-B2 | Isocyanate composition, method for producing isocyanate composition, and method for producing isocyanate polymer | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2021-09-14 | — | — | US | disclosed |
| US-20080125549-A1 | COUPLING OF LIVING CARBOCATIONIC POLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 2008-05-29 | — | — | US | disclosed |
| US-20070161734-A1 | Comprising clay and cationic mediator such as imidazolium compound wherein cationic mediator comprises hydrophobic unit and cationic unit; use in preparing products such as tires with improved and well-balanced properties including gas impermeability, cure rates, and superior mechanical characteristics | BRIDGESTONE CORPORATION (JP) | 2007-07-12 | — | — | US | disclosed |
| EP-0319123-B1 | Process for producing unsaturated fatty acid or unsaturated hydrocarbon | AGENCY IND SCIENCE TECHN (JP) | 1995-05-17 | — | — | EP | disclosed |
| US-5059532-A | Culturing with a fatty acid, fatty acid alkali metal salt or an ester or with an alkane or a haloalkane; dehydrogenation; efficiency; chemical intermediates | AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY (JP) | 1991-10-22 | — | — | US | disclosed |
| EP-0319123-A2 | Process for producing unsaturated fatty acid or unsaturated hydrocarbon | The Agency of Industrial Science and Technology (JP) | 1989-06-07 | — | — | EP | disclosed |
| EP-0132113-B1 | COMPOSITIONS USEFUL FOR PRODUCING ANALGESIA | THE PROCTER & GAMBLE COMPANY (US) | 1988-10-26 | — | — | EP | disclosed |
| US-4618722-A | Preparation of organic sulfides | PHILLIPS PETROLEUM COMPANY (US) | 1986-10-21 | — | — | US | disclosed |
| US-4564633-A | N-OXYBENZYL/ALKENAMIDE | THE PROCTER & GAMBLE COMPANY (US) | 1986-01-14 | — | — | US | disclosed |
| EP-0132113-A1 | Compositions useful for producing analgesia | THE PROCTER & GAMBLE COMPANY (US) | 1985-01-23 | — | — | EP | disclosed |
| US-4493848-A | N-((SUBSTITUTED PHENYL)METHYL)CIS MONOUNSATURATED ALKENAMIDE) | THE PROCTER & GAMBLE COMPANY (US) | 1985-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11548975-B2 | Isocyanate composition and method for producing isocyanate polymer | IDH3A, IDH2, IDH3B | FAAH 1066/4885TRPV1 1828/4885TSHR 4885/4885 |
| US-20230114799-A1 | ISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANATE POLYMER | IDH3A, IDH2, IDH3B | FAAH 1022/4885TRPV1 2034/4885TSHR 4885/4885 |
| US-11118001-B2 | Isocyanate composition, method for producing isocyanate composition, and method for producing isocyanate polymer | IDH3A, IPO4, IDH3B | FAAH 2247/4885TRPV1 654/4885TSHR 4584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.